These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25799440)

  • 1. Improved specificity of TALE-based genome editing using an expanded RVD repertoire.
    Miller JC; Zhang L; Xia DF; Campo JJ; Ankoudinova IV; Guschin DY; Babiarz JE; Meng X; Hinkley SJ; Lam SC; Paschon DE; Vincent AI; Dulay GP; Barlow KA; Shivak DA; Leung E; Kim JD; Amora R; Urnov FD; Gregory PD; Rebar EJ
    Nat Methods; 2015 May; 12(5):465-71. PubMed ID: 25799440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Context and number of noncanonical repeat variable diresidues impede the design of TALE proteins with improved DNA targeting.
    Anderson JT; Rogers JM; Barrera LA; Bulyk ML
    Protein Sci; 2020 Feb; 29(2):606-616. PubMed ID: 31833142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of selected genome loci using de novo-engineered transcription activator-like effector (TALE)-type transcription factors.
    Morbitzer R; Römer P; Boch J; Lahaye T
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21617-22. PubMed ID: 21106758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TALE: a tale of genome editing.
    Zhang M; Wang F; Li S; Wang Y; Bai Y; Xu X
    Prog Biophys Mol Biol; 2014 Jan; 114(1):25-32. PubMed ID: 24291598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-RVD mutations that enhance the dynamics of the TAL repeat array along the superhelical axis improve TALEN genome editing efficacy.
    Tochio N; Umehara K; Uewaki JI; Flechsig H; Kondo M; Dewa T; Sakuma T; Yamamoto T; Saitoh T; Togashi Y; Tate SI
    Sci Rep; 2016 Nov; 6():37887. PubMed ID: 27883072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multiplexed transcription activator-like effector system for detecting specific DNA sequences.
    Honarmand A; Mayall R; George I; Oberding L; Dastidar H; Fegan J; Chaudhuri S; Dole J; Feng S; Hoang D; Moges R; Osgood J; Remondini T; van der Meulen WK; Wang S; Wintersinger C; Zaparoli Zucoloto A; Chatfield-Reed K; Arcellana-Panlilio M; Nygren A
    ACS Synth Biol; 2014 Dec; 3(12):953-5. PubMed ID: 25524096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FusX: A Rapid One-Step Transcription Activator-Like Effector Assembly System for Genome Science.
    Ma AC; McNulty MS; Poshusta TL; Campbell JM; Martínez-Gálvez G; Argue DP; Lee HB; Urban MD; Bullard CE; Blackburn PR; Man TK; Clark KJ; Ekker SC
    Hum Gene Ther; 2016 Jun; 27(6):451-63. PubMed ID: 26854857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAL effectors: tools for DNA targeting.
    Jankele R; Svoboda P
    Brief Funct Genomics; 2014 Sep; 13(5):409-19. PubMed ID: 24907364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted genome regulation and modification using transcription activator-like effectors.
    Scott JN; Kupinski AP; Boyes J
    FEBS J; 2014 Oct; 281(20):4583-97. PubMed ID: 25124066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Development of TALE Nucleases for Biotechnology.
    Ousterout DG; Gersbach CA
    Methods Mol Biol; 2016; 1338():27-42. PubMed ID: 26443211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transcription activator-like effector toolbox for genome engineering.
    Sanjana NE; Cong L; Zhou Y; Cunniff MM; Feng G; Zhang F
    Nat Protoc; 2012 Jan; 7(1):171-92. PubMed ID: 22222791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A TALE nuclease architecture for efficient genome editing.
    Miller JC; Tan S; Qiao G; Barlow KA; Wang J; Xia DF; Meng X; Paschon DE; Leung E; Hinkley SJ; Dulay GP; Hua KL; Ankoudinova I; Cost GJ; Urnov FD; Zhang HS; Holmes MC; Zhang L; Gregory PD; Rebar EJ
    Nat Biotechnol; 2011 Feb; 29(2):143-8. PubMed ID: 21179091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TALE activators regulate gene expression in a position- and strand-dependent manner in mammalian cells.
    Uhde-Stone C; Cheung E; Lu B
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1189-94. PubMed ID: 24380858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of TALE-DNA interactions suggests polarity effects.
    Meckler JF; Bhakta MS; Kim MS; Ovadia R; Habrian CH; Zykovich A; Yu A; Lockwood SH; Morbitzer R; Elsäesser J; Lahaye T; Segal DJ; Baldwin EP
    Nucleic Acids Res; 2013 Apr; 41(7):4118-28. PubMed ID: 23408851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transcription activator-like effector (TALE) induction system mediated by proteolysis.
    Copeland MF; Politz MC; Johnson CB; Markley AL; Pfleger BF
    Nat Chem Biol; 2016 Apr; 12(4):254-60. PubMed ID: 26854666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeat 1 of TAL effectors affects target specificity for the base at position zero.
    Schreiber T; Bonas U
    Nucleic Acids Res; 2014 Jun; 42(11):7160-9. PubMed ID: 24792160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription activator-like effector proteins induce the expression of the frataxin gene.
    Tremblay JP; Chapdelaine P; Coulombe Z; Rousseau J
    Hum Gene Ther; 2012 Aug; 23(8):883-90. PubMed ID: 22587705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From dead leaf, to new life: TAL effectors as tools for synthetic biology.
    de Lange O; Binder A; Lahaye T
    Plant J; 2014 Jun; 78(5):753-71. PubMed ID: 24602153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational elasticity can facilitate TALE-DNA recognition.
    Lei H; Sun J; Baldwin EP; Segal DJ; Duan Y
    Adv Protein Chem Struct Biol; 2014; 94():347-64. PubMed ID: 24629191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in transcription activator-like effectors--a review].
    Yu T; Li L; Lin J
    Sheng Wu Gong Cheng Xue Bao; 2015 Jul; 31(7):1024-38. PubMed ID: 26647578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.